Skip to content
OpenCapital
Get started

Vericel VCEL Epicel — Product sales, net

Other product segments

M A C I Implants and kits
$56.4M+21.8%
MACI implants, kits, and instruments
$41.51M+30.4%
Biopsy kits
$606K+1.7%

Similar metrics at other companies

Tarsus Pharmaceuticals, Inc. logo
TARSProduct sales, net — Total revenues
$145.39M+85.6%
Aurinia Pharmaceuticals logo
AUPHNet product sales — Revenue
$73.56M+22.7%
BioCryst Pharmaceuticals logo
BCRXProduct sales, net — Total revenues
$151.4M+5.3%
Vertex Pharmaceuticals logo
VRTXProduct revenues, net — Product revenues, net
$2.99B+8.2%
Rogers Corporation logo
ROGElastomeric Material Solutions — Net Sales
$88.4M+7.0%
Precigen logo
PGENProduct revenues, net — Total revenues
$21.83M+10,653%

Other financials

Income statement

See full
Revenue$68.4M+30.1%
Gross profit$49.3M+35.8%
Operating income-$8.1M+37.0%
Net income-$6.3M+44.0%
EPS (diluted)-$0.12+47.8%

Balance sheet

See full
Cash & equivalents$109.3M+37.1%
Total debt$95.0M-4.6%
Total equity$356.2M+20.6%
Total assets$485.6M+14.4%

Cash flow

See full
Operating cash flow$16.4M+148%
CapEx$1.3M-91.2%
Free cash flow$15.1M+299%

Valuation

See full
Market cap$2.06B-26.8%
Enterprise value$2.05B-28.0%
P/E96.1×-850×
P/S7.1×-4.7×

Profitability

See full
Gross margin74.8%+2.3pp
Operating margin5.4%+4.6pp
Net margin7.3%+6.1pp
FCF margin16.3%—

Returns & leverage

See full
Return on equity6.6%+5.5pp
Debt / equity0.3×-0.1×
Current ratio5.2×+0.2×

Where this comes from

Reported directly by Vericel in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's epicel — product sales, net.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vericel's epicel — product sales, net?
Vericel (VCEL) reported epicel — product sales, net of $10.89M in Q1 2026.
How has Vericel's epicel — product sales, net changed year-over-year?
Vericel's epicel — product sales, net increased by 119.3% year-over-year, from $4.96M to $10.89M.
What is the long-term trend for Vericel's epicel — product sales, net?
Over 4 years (2021 to 2025), Vericel's epicel — product sales, net has grown at a -6.3% compound annual growth rate (CAGR), from $41.52M to $32.07M.
What does epicel — product sales, net mean?
Represents the total net revenue generated from the sale of the Epicel product line after accounting for returns, allowances, and discounts. This metric serves as a primary indicator of market demand and commercial adoption for this specific therapeutic offering. Tracking these sales provides insight into the product's lifecycle performance and its contribution to the company's overall top-line growth.